Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.480
-0.510 (-25.63%)
At close: Jul 24, 2026, 4:00 PM EDT
1.450
-0.030 (-2.03%)
After-hours: Jul 24, 2026, 7:59 PM EDT
Codexis Revenue
Codexis had revenue of $15.25M in the quarter ending March 31, 2026, with 102.15% growth. This brings the company's revenue in the last twelve months to $78.09M, up 56.76% year-over-year. In the year 2025, Codexis had annual revenue of $70.39M with 18.61% growth.
Revenue (ttm)
$78.09M
Revenue Growth
+56.76%
P/S Ratio
1.72
Revenue / Employee
$534,877
Employees
146
Market Cap
134.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 70.39M | 11.04M | 18.61% |
| Dec 31, 2024 | 59.35M | -10.80M | -15.39% |
| Dec 31, 2023 | 70.14M | -68.45M | -49.39% |
| Dec 31, 2022 | 138.59M | 33.84M | 32.30% |
| Dec 31, 2021 | 104.75M | 35.70M | 51.69% |
| Dec 31, 2020 | 69.06M | 598.00K | 0.87% |
| Dec 31, 2019 | 68.46M | 7.86M | 12.98% |
| Dec 31, 2018 | 60.59M | 10.57M | 21.13% |
| Dec 31, 2017 | 50.02M | 1.19M | 2.43% |
| Dec 31, 2016 | 48.84M | 7.03M | 16.82% |
| Dec 31, 2015 | 41.80M | 6.50M | 18.40% |
| Dec 31, 2014 | 35.31M | 3.39M | 10.60% |
| Dec 31, 2013 | 31.92M | -56.38M | -63.85% |
| Dec 31, 2012 | 88.30M | -35.57M | -28.71% |
| Dec 31, 2011 | 123.87M | 16.76M | 15.65% |
| Dec 31, 2010 | 107.10M | 24.20M | 29.18% |
| Dec 31, 2009 | 82.91M | 32.43M | 64.25% |
| Dec 31, 2008 | 50.48M | 25.15M | 99.26% |
| Dec 31, 2007 | 25.33M | 13.21M | 108.90% |
| Dec 31, 2006 | 12.13M | 343.00K | 2.91% |
| Dec 31, 2005 | 11.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cue Biopharma | 32.73M |
| Cibus | 4.29M |
| Kazia Therapeutics | 1.27M |
| Molecular Partners AG | 856.30K |
| Connect Biopharma Holdings | 233.00K |
| Genelux | 8.00K |
| Fractyl Health | 3.00K |
CDXS News
- 1 day ago - Codexis 16.667M share Spot Secondary priced at $1.50 - TheFly
- 2 days ago - Codexis Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 2 days ago - Codexis announces common stock offering, no amount given - TheFly
- 2 days ago - Codexis Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Codexis Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Codexis Slides: Corporate presentation - Filings
- 2 months ago - Codexis reports Q1 EPS (10c), consensus (10c) - TheFly
- 2 months ago - Codexis backs FY26 revenue view $72M-$76M, consensus $74.24M - TheFly